Home » Health » Title: Alzheimer’s: Targeting Circadian Rhythm to Slow Neurodegeneration

Title: Alzheimer’s: Targeting Circadian Rhythm to Slow Neurodegeneration

by Dr. Michael Lee – Health Editor

## Restoring ⁤Circadian Rhythm⁤ Function Shows Promise in Alzheimer’s ⁤Disease Models

New research from Washington University school ⁣of Medicine in st. Louis suggests that ⁢bolstering the body’s‌ natural daily rhythms may offer ⁣a novel therapeutic avenue for Alzheimer’s disease.‍ published in *Nature Aging*, the study ⁢details‌ how manipulating a key protein involved in circadian regulation can ⁤reduce damaging tau buildup and protect brain⁤ tissue in mouse⁢ models of the disease.

the research, led by Erik⁢ Musiek, MD, PhD, and first author Jiyeon ​Lee, PhD, focused⁣ on the⁤ protein REV-ERBα, a regulator of metabolism and inflammation tied to the ​body’s 24-hour ‌clock. Previous studies ⁤indicated REV-ERBα influences levels of nicotinamide ​adenine dinucleotide (NAD+), a crucial molecule for cellular energy, DNA repair,‌ and overall metabolic‌ health. declining NAD+ levels are a hallmark of‌ both brain aging and neurodegenerative diseases.

Researchers⁣ investigated the ​impact of reducing REV-ERBα activity in mice. They ‍observed that genetically deleting the protein – both throughout the body and specifically⁢ within astrocytes, supportive cells in the brain – led to a meaningful‍ increase in NAD+ levels. This suggests that inhibiting REV-ERBα directly enhances NAD+ production within the brain.

Further experiments ⁤confirmed this protective effect. Blocking REV-ERBα, using both genetic techniques and ⁤a newly developed drug already under investigation for amyloid-β and⁢ Parkinson’s disease, not only raised NAD+ levels but also ‍mitigated brain damage associated with tau protein ⁣accumulation. Tau aggregates are known to disrupt neuronal ​function ⁢and are a key characteristic⁢ of⁣ Alzheimer’s disease.

these findings indicate that restoring optimal function to the body’s internal clock, specifically through REV-ERBα ​inhibition, ‌could represent⁤ a new strategy for preventing tau buildup and ⁤potentially slowing or halting the progression of Alzheimer’s ‍disease. The research highlights the critical link between circadian rhythm health and brain resilience,⁢ opening doors for future treatments focused on resetting and reinforcing these‌ vital ⁤biological processes.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.